XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

This study has been withdrawn prior to recruitment.

( Alternate study projected to assess imaging endpoints versus clinical endpoints. )

Study NCT00226668 Information provided by Celtic Pharma Development Services

First Received: September 23, 2005 Last Updated: December 27, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been withdrawn prior to recruitment.
Estimated Study Completion Date:	January 2008
Estimated Primary Completion Date:	No date given